Version 5.4
Bos taurus Protein: BT.18113
Summary
InnateDB Protein IDBP-684377.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.18113
Protein Name interleukin enhancer binding factor 2
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000016549
InnateDB Gene IDBG-632738 (BT.18113)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 139 interaction(s) predicted by orthology.
Predicted by orthology
Total 139 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0003723 RNA binding
GO:0003725 double-stranded RNA binding
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0016740 transferase activity
GO:0044822 poly(A) RNA binding
Biological Process
GO:0006351 transcription, DNA-templated
GO:0006955 immune response
GO:0045893 positive regulation of transcription, DNA-templated
Cellular Component
GO:0005634 nucleus
GO:0005730 nucleolus
GO:0016020 membrane
GO:0030529 ribonucleoprotein complex
Protein Structure and Domains
PDB ID
InterPro IPR006116 2-5-oligoadenylate synthetase, N-terminal
IPR006561 DZF domain
PFAM PF07528
PRINTS
PIRSF
SMART SM00572
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F2Z4E7
UniProt Splice Variant
Entrez Gene 539760
UniGene Bt.18113
RefSeq NP_001033276
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02007184
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca